Author

P. Micke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Mezheyeuski· 2 shared A. De Reynies· 1 shared A. Edvinsson· 1 shared A. Martin-Bernabe· 1 shared A. Miranda· 1 shared A. Portyanko· 1 shared A. W. Zhang· 1 shared B. Glimelius· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Mezheyeuski

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The ratio of cytotoxic lymphocytes to M2-like macrophages is prognostic in immunogenic tumors

A. Mezheyeuski, M. Backman, J. Mattsson, A. Martin-Bernabe, C. Larsson, I. Hrynchyk, K. Hammarström, S. Ström, J. Ekström, S. Mauchanski, S. Khelashvili, M. Agnarsdottir, P.-H. Edqvist, J. Huvila, U. Segersten, , T. Sjöblom

The paper identifies a prognostic signature based on the ratio of cytotoxic lymphocytes to M2-like macrophages in tumor microenvironments, showing better survival prediction than existing immune scores in colon cancer and other high-mutation burden cancers.

bioRxiv · Mar 24, 2021 · PreprintCancer Biology

The protein expression profile of ACE2 in human tissues

F. Hikmet, L. Mear, A. Edvinsson, P. Micke, M. Uhlen, C. Lindskog

This study maps ACE2 protein expression across >150 human cell types, revealing tissue-specific patterns relevant to SARS-CoV-2 infection.

bioRxiv · Mar 31, 2020Cell Biology

Cancer stemness, intratumoral heterogeneity, and immune response across cancers

A. Miranda, P. T. Hamilton, A. W. Zhang, E. Becht, A. Mezheyeuski, J. Bruun, P. Micke, A. De Reynies, B. H. Nelson

The paper assesses the relationship between cancer stemness and immune response across 21 solid cancers, finding negative associations between stemness and anticancer immunity.

bioRxiv · Jun 20, 2018Cancer Biology